483 Roundup: Seven Companies Cited for Quality Transgressions By Sam | September 11, 2019 The FDA hit seven drugmakers for quality-related violations, including issues with shared equipment and complaint evaluation. Source: Drug GMP Report Posted in Drug GMP Report